In the present study, we aimed to explore the longitudinal progression of the tau SUVr values and of cortical atrophy after a mean time interval of 2 years in a cohort of well-characterized AD patients at the mild cognitive impairment/mild dementia stages compared with controls, and their relationships with baseline regional tau load, and clinical decline in specific cognitive domains. The gene discussed is MAPT; the disease is Cognitive impairment.